FRAGMIN Side Effects

7018361-6 | International Normalised Ratio Increased, Prothrombin Time Prolonged
on Sep 08, 2010 Male patient from UNITED STATES , 68 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased, prothrombin time prolonged. Fragmin dosage: 6500 Iu, 2x/day, Subcutaneous. During the same period patient was treated with WARFARIN SODIUM (10 Mg Daily, 5 Mg Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.

7009130-1 | International Normalised Ratio Increased, Refusal Of Treatment By Patient
Patient was taking Fragmin (View Usage). Patient had the following side effects: international normalised ratio increased, refusal of treatment by patient on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) and. Fragmin dosage: 6500 Iu, 2x/day, Subcutaneous. During the same period patient was treated with WARFARIN SODIUM (25 Mg, Daily ; 5 Mg, Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.

7007587-3 | Accidental Overdose, Cerebral Haemorrhage, Contraindication To Medical Treatment
Adverse event was reported on Sep 07, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: 5000 Iu, Single) was diagnosed with thrombosis prophylaxis and. Location: SWEDEN , 79 years of age, After Fragmin was administered, patient had the following side effects: accidental overdose, cerebral haemorrhage, contraindication to medical treatment.

7007583-6 | Heart Rate Increased
on Sep 06, 2010 Female patient from UNITED KINGDOM , 62 years of age, was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased. Fragmin dosage: 12500 Iu.


7007574-5 | Anxiety, Fibrin D Dimer Increased, Injection Site Extravasation, Injection Site Swelling, Injection Site Vesicles
on Sep 07, 2010 Female patient from JAPAN , 62 years of age, weighting 160.9 lb, was diagnosed with thrombosis prophylaxis and was treated with Fragmin (View Usage). Patient had the following side effects: anxiety (What is anxiety?), fibrin d dimer increased, injection site extravasation, injection site swelling, injection site vesicles. Fragmin dosage: 10000 Iu, Iv Drip. During the same period patient was treated with AMINOPHYLLIN (2000 Ml, Iv Drip) (View Aminophyllin Review and Aminophyllin Label ), HUMULIN (INNSULIN HUMAN, INSULIN ISOPHANE, HUMAN BIOSYNTHETIC) (View Humulin (innsulin Human, Insulin Isophane, Human Biosynthetic) Review and Humulin (innsulin Human, Insulin Isophane, Human Biosynthetic) Label ), DEXTROSE 5% (View Dextrose 5% Review and Dextrose 5% Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROPOFOL (PROPOFOL) INJECTION (View Propofol (propofol) Injection Review and Propofol (propofol) Injection Label ), MINOCYCLINE (MINOCYCLINE) INJECTION (View Minocycline (minocycline) Injection Review and Minocycline (minocycline) Injection Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

7007509-5 | Dyspnoea, Oral Disorder
Patient was taking Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: dyspnoea, oral disorder on Sep 01, 2010 from PORTUGAL Additional patient health information: Female patient , 43 years of age, weighting 149.9 lb, was diagnosed with antiphospholipid antibodies positive and. Fragmin dosage: Subcutaneous. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE) (View Hydroxychloroquine Sulfate (hydroxychloroquine Sulfate) Review and Hydroxychloroquine Sulfate (hydroxychloroquine Sulfate) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

7006389-1 | Retinal Detachment, Vitreous Haemorrhage
Adverse event was reported on Aug 26, 2010 by a Female patient taking Fragmin (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: GERMANY , 79 years of age, Patient experienced the following unwanted or unexpected effects: retinal detachment, vitreous haemorrhage.

6964737-2 | Caesarean Section, Gestational Diabetes, Hypoaesthesia, Injection Site Pain, Pregnancy
on Aug 19, 2010 Female patient from ISRAEL , 40 years of age, was diagnosed with coagulation factor viii level increased and was treated with Fragmin (View Usage). Patient had the following side effects: caesarean section, gestational diabetes, hypoaesthesia, injection site pain, pregnancy (What is pregnancy?). Fragmin dosage: .

6959472-0 | Pancreatic Carcinoma
on Aug 17, 2010 Female patient from UNITED STATES , 58 years of age, weighting 168.0 lb, was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: pancreatic carcinoma. Fragmin dosage: .

6959471-9 |
Patient was taking Fragmin (View Usage). on Aug 18, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 198.4 lb, . Fragmin dosage: 18000 Iu, 1 X/day, Subcutaneous.

6959470-7 | Neoplasm Malignant
Adverse event was reported on Aug 16, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: 5000 Iu, Daily, 15000 Iu, Daily) . Location: UNITED STATES , 43 years of age, Patient had the following side effects: neoplasm malignant.

6959469-0 | Inflammation, Joint Swelling
on Aug 16, 2010 Male patient from UNITED STATES , 72 years of age, weighting 220.0 lb, was diagnosed with thrombosis and was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: inflammation, joint swelling. Fragmin dosage: 18000 Iu, 1x/day, Subcutaneous. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ZOCOR (View Zocor Review and Zocor Label ), LASIX (View Lasix Review and Lasix Label ), CELEXA (View Celexa Review and Celexa Label ), COMBIVENT (IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE) INHALATION VAPOR, (View Combivent (ipratropium Bromide, Salbutamol Sulfate) Inhalation Vapor, Review and Combivent (ipratropium Bromide, Salbutamol Sulfate) Inhalation Vapor, Label ), CARDIZEM (DILTIAZEM HYDROCHLORIDE) MODIFIED RELEASE TABLET (View Cardizem (diltiazem Hydrochloride) Modified-release Tablet Review and Cardizem (diltiazem Hydrochloride) Modified-release Tablet Label ).

6959464-1 | Abasia, Alopecia, Contusion, Hypertension, Lacrimation Increased, Onychomadesis, Pain In Extremity, Paraesthesia
on Aug 18, 2010 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with breast cancer (What is breast cancer?), coagulopathy and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, alopecia, contusion, hypertension, lacrimation increased, onychomadesis, pain in extremity, paraesthesia. Fragmin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), BENADRYL (View Benadryl Review and Benadryl Label ), AVASTIN (View Avastin Review and Avastin Label ).

6946283-5 | Chest X-ray Abnormal, Dyskinesia, Nausea, Pulmonary Embolism, White Blood Cell Count Decreased
Patient was taking Fragmin (View Usage). Patient had the following side effects: chest x-ray abnormal, dyskinesia, nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?), white blood cell count decreased on Jul 29, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, was diagnosed with fibrin d dimer increased, schizophrenia and. Fragmin dosage: Subcutaneous. During the same period patient was treated with CLOZARIL (450 Mg, 1x/day, Oral) (View Clozaril Review and Clozaril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6946282-3 | Deep Vein Thrombosis, Ischaemic Cerebral Infarction
Adverse event was reported on Aug 12, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: SWITZERLAND , 34 years of age, After Fragmin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), ischaemic cerebral infarction. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6939536-8 | Extradural Haematoma, Micturition Disorder, Pain In Extremity, Paraparesis
on Aug 05, 2010 Male patient from NETHERLANDS , 70 years of age, weighting 145.5 lb, was diagnosed with dialysis (What is dialysis?) and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: extradural haematoma, micturition disorder, pain in extremity, paraparesis. Fragmin dosage: 7500 Iu, Intravenous. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NEXIUM (View Nexium Review and Nexium Label ), SELOKEEN (METOPROLOL TARTRATE) (View Selokeen (metoprolol Tartrate) Review and Selokeen (metoprolol Tartrate) Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LYRICA (View Lyrica Review and Lyrica Label ), NOVOLOG (View Novolog Review and Novolog Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6929571-8 | Abasia, Alopecia, Contusion, Hypertension, Lacrimation Increased, Onychomadesis, Pain In Extremity, Paraesthesia
on Aug 02, 2010 Female patient from UNITED STATES , weighting 185.0 lb, was diagnosed with breast cancer (What is breast cancer?), coagulopathy and was treated with Fragmin (View Usage). Patient had the following side effects: abasia, alopecia, contusion, hypertension, lacrimation increased, onychomadesis, pain in extremity, paraesthesia. Fragmin dosage: . During the same period patient was treated with TAXOL (View Taxol Review and Taxol Label ), BENADRYL (View Benadryl Review and Benadryl Label ), AVASTIN (View Avastin Review and Avastin Label ).

6907182-8 | Anal Atresia, Breech Presentation, Caesarean Section, Congenital Hand Malformation, Foetal Growth Restriction, Maternal Condition Affecting Foetus, Premature Baby
Patient was taking Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: anal atresia, breech presentation, caesarean section, congenital hand malformation, foetal growth restriction, maternal condition affecting foetus, premature baby on Jul 19, 2010 from NORWAY Additional patient health information: Female patient , weighting 4.85 lb, was diagnosed with complication of pregnancy, hypertension and. Fragmin dosage: 5000 Iu, 1x/day, Transplacental. During the same period patient was treated with TRANDATE (100 Mg, 2x/day, Transplacental) (View Trandate Review and Trandate Label ).

6905370-8 | Ammonia Increased, Ascites, Colonic Polyp, Gastric Varices, Haematocrit Decreased, Haemoglobin Decreased, Haemorrhoidal Haemorrhage, Lower Gastrointestinal Haemorrhage, Portal Hypertension
Adverse event was reported on Jul 21, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: ) was diagnosed with myelofibrosis and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: ammonia increased, ascites, colonic polyp (What is colonic polyp?), gastric varices, haematocrit decreased, haemoglobin decreased, haemorrhoidal haemorrhage, lower gastrointestinal haemorrhage, portal hypertension. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KEPPRA (View Keppra Review and Keppra Label ), NADOLOL (View Nadolol Review and Nadolol Label ), PREVACID (View Prevacid Review and Prevacid Label ), TYLENOL W/ CODEINE (View Tylenol W/ Codeine Review and Tylenol W/ Codeine Label ). Patient was hospitalized.

6895504-6 | Hepatic Neoplasm Malignant, Malignant Neoplasm Progression
on Jul 14, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with thrombosis prophylaxis and was treated with Fragmin (View Usage). Patient had the following side effects: hepatic neoplasm malignant, malignant neoplasm progression. Fragmin dosage: 18000 Iu, Daily, Subcutaneous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMETHICONE (SIMETICONE) (View Simethicone (simeticone) Review and Simethicone (simeticone) Label ), MORPHINE SULFATE INJ (View Morphine Sulfate Inj Review and Morphine Sulfate Inj Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6895467-3 | Abdominal Pain, Chills, Headache, Hypersensitivity, International Normalised Ratio Decreased, Tenderness
on Jul 13, 2010 Male patient from UNITED STATES , 43 years of age, was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), chills, headache (What is headache?), hypersensitivity, international normalised ratio decreased, tenderness. Fragmin dosage: 16.400 Iu, 1x/day, Subcutaneous. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), INTERFERON ALFA 2B (INTERFERON ALFA 2B) (View Interferon Alfa-2b (interferon Alfa-2b) Review and Interferon Alfa-2b (interferon Alfa-2b) Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), ACETAMINOPHEN AND OXYCODONE HCL (View Acetaminophen And Oxycodone Hcl Review and Acetaminophen And Oxycodone Hcl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6894535-X | Chest Pain, Chest X-ray Abnormal, Dyskinesia, Dyspnoea, Fibrin D Dimer Increased, Nausea, Pulmonary Embolism
Patient was taking Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), chest x-ray abnormal, dyskinesia, dyspnoea, fibrin d dimer increased, nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?) on Jul 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, was diagnosed with fibrin d dimer increased, schizophrenia and. Fragmin dosage: Subcutaneous. During the same period patient was treated with CLOZARIL (450 Mg, 1x/day, Oral) (View Clozaril Review and Clozaril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6870854-8 | Fall, Head Injury, International Normalised Ratio Decreased, Intracranial Pressure Increased, Subdural Haemorrhage
Adverse event was reported on Jul 09, 2010 by a Female patient taking Fragmin (View Usage) (Dosage: 5000 Iu, Subcutaneous) was diagnosed with arrhythmia prophylaxis, atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED KINGDOM , 72 years of age, weighting 240.3 lb, Patient had the following side effects: fall (What is fall?), head injury, international normalised ratio decreased, intracranial pressure increased, subdural haemorrhage. During the same period patient was treated with WARFARIN SODIUM (Oral) (View Warfarin Sodium Review and Warfarin Sodium Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6870853-6 | Hepatitis Toxic, Thrombophlebitis, Thrombosis
on Jul 09, 2010 Male patient from SWEDEN , 52 years of age, was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: hepatitis toxic, thrombophlebitis, thrombosis. Fragmin dosage: 15000 Iu, Subcutaneous ; 12500 Iu, Subcutaneous. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), OPTINATE SEPTIMUM (RISEDRONATE SODIUM) (View Optinate Septimum (risedronate Sodium) Review and Optinate Septimum (risedronate Sodium) Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), KALCIPOS D (CALCIUM CARBONATE, COLECALCIFEROL) (View Kalcipos-d (calcium Carbonate, Colecalciferol) Review and Kalcipos-d (calcium Carbonate, Colecalciferol) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), THEO DUR SLOW RELEASE (THEOPHYLLINE) (View Theo-dur - Slow Release (theophylline) Review and Theo-dur - Slow Release (theophylline) Label ). Patient was hospitalized.

6870852-4 | Cerebral Haemorrhage
on Jul 09, 2010 Male patient from SWEDEN , 53 years of age, was diagnosed with acute myocardial infarction, hypertension and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Fragmin dosage: . During the same period patient was treated with ASPIRIN (75 Mg, Oral) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg Daily, Oral) (View Plavix Review and Plavix Label ), MOVICOL (MACROGOL, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLO (View Movicol (macrogol, Potassium Chloride, Sodium Bicarbonate, Sodium Chlo Review and Movicol (macrogol, Potassium Chloride, Sodium Bicarbonate, Sodium Chlo Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6870851-2 | Blood Bilirubin Increased, Dialysis, Renal Impairment
Patient was taking Fragmin (View Usage). Patient had the following side effects: blood bilirubin increased, dialysis (What is dialysis?), renal impairment on Jul 08, 2010 from ISRAEL Additional patient health information: Female patient , 74 years of age, . Fragmin dosage: 5000, 1/xday.

6869769-0 | Cerebral Haemorrhage
Adverse event was reported on Jul 09, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: Unk) was diagnosed with acute myocardial infarction, hypertension and. Location: SWEDEN , 53 years of age, After Fragmin was administered, patient had the following side effects: cerebral haemorrhage. During the same period patient was treated with TROMBYL (75 Mg, Unk) (View Trombyl Review and Trombyl Label ), PLAVIX (75 Mg Daily) (View Plavix Review and Plavix Label ), NULYTELY (Unk) (View Nulytely Review and Nulytely Label ), GABAPENTIN (Unk) (View Gabapentin Review and Gabapentin Label ), CITALOPRAM (Unk) (View Citalopram Review and Citalopram Label ), SELOKEN (Unk) (View Seloken Review and Seloken Label ). Patient was hospitalized.

6861297-1 | Anal Atresia, Breech Presentation, Caesarean Section, Congenital Hand Malformation, Foetal Growth Restriction, Premature Baby
on Jun 30, 2010 Female patient from NORWAY , weighting 4.85 lb, was diagnosed with complication of pregnancy, hypertension and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: anal atresia, breech presentation, caesarean section, congenital hand malformation, foetal growth restriction, premature baby. Fragmin dosage: 5000 Iu, 1x/day, Transplacental. During the same period patient was treated with TRANDATE (100 Mg, 2x/day, Transplacental) (View Trandate Review and Trandate Label ).

6857929-4 | Accidental Overdose, Contraindication To Medical Treatment, Haemorrhage Intracranial
on Jul 01, 2010 Male patient from SWEDEN , 79 years of age, was diagnosed with thrombosis prophylaxis and was treated with Fragmin (View Usage). Patient had the following side effects: accidental overdose, contraindication to medical treatment, haemorrhage intracranial. Fragmin dosage: 100000 Iu.

6847387-8 | Abortion Spontaneous, Application Site Bleeding, Application Site Pain, Haematoma
Patient was taking Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: abortion spontaneous, application site bleeding, application site pain, haematoma on Jun 28, 2010 from BRAZIL Additional patient health information: Female patient , 38 years of age, was diagnosed with prophylaxis of abortion and. Fragmin dosage: 5000 Iu, 1x/day Subcutaneous. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CELEXANE (HEPARIN FRACTION, SODIUM SALT) (View Celexane (heparin-fraction, Sodium Salt) Review and Celexane (heparin-fraction, Sodium Salt) Label ).

6847386-6 | Dyspnoea, Oral Disorder
Adverse event was reported on Jun 28, 2010 by a Female patient taking Fragmin (View Usage) (Dosage: Subcutaneous) was diagnosed with antiphospholipid antibodies positive and. Location: PORTUGAL , 43 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, oral disorder. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

6845529-1 | Visual Acuity Reduced
on Jun 27, 2010 Female patient from UNITED STATES , 54 years of age, weighting 160.1 lb, was diagnosed with lower limb fracture, postoperative care, thrombosis prophylaxis and was treated with Fragmin (View Usage). Patient had the following side effects: visual acuity reduced. Fragmin dosage: 5000 Iu, 1x/day. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ).

6838300-8 | Haemorrhage, Impaired Healing, Wound Dehiscence
on Jun 22, 2010 Male patient from AUSTRIA , 63 years of age, weighting 231.5 lb, was diagnosed with thrombosis prophylaxis and was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: haemorrhage, impaired healing, wound dehiscence. Fragmin dosage: 5000 Iu, 1x/day. Patient was hospitalized.

6821700-X | Haemolysis, Liver Function Test Abnormal, Thrombocytopenia
Patient was taking Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: haemolysis, liver function test abnormal, thrombocytopenia on Jun 21, 2010 from ITALY Additional patient health information: Male patient , 98 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Fragmin dosage: 1 Unit Daily, Subcutaneous. During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), PLACTIDIL (PICOTAMIDE) (View Plactidil (picotamide) Review and Plactidil (picotamide) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZOFENOPRIL (ZOFENOPRIL) (View Zofenopril (zofenopril) Review and Zofenopril (zofenopril) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NITROGLICERINA (GLYCERYL TRINITRATE) (View Nitroglicerina (glyceryl Trinitrate) Review and Nitroglicerina (glyceryl Trinitrate) Label ). Patient was hospitalized.

6818838-X | Accidental Overdose, Contraindication To Medical Treatment, Haemorrhage Intracranial
Adverse event was reported on Jun 15, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: 100000 Iu) . Location: SWEDEN , 79 years of age, Patient had the following side effects: accidental overdose, contraindication to medical treatment, haemorrhage intracranial.

6818837-8 | Haemolysis, Liver Function Test Abnormal, Thrombocytopenia
on Jun 17, 2010 Male patient from ITALY , 98 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: haemolysis, liver function test abnormal, thrombocytopenia. Fragmin dosage: 1 Unit Daily, Subcutaneous. During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), PLACTIDIL (PICOTAMIDE) (View Plactidil (picotamide) Review and Plactidil (picotamide) Label ). Patient was hospitalized.

6818835-4 | Fall, Head Injury, International Normalised Ratio Decreased, Intracranial Pressure Increased, Subdural Haemorrhage
on Jun 15, 2010 Female patient from UNITED KINGDOM , 72 years of age, weighting 240.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), head injury, international normalised ratio decreased, intracranial pressure increased, subdural haemorrhage. Fragmin dosage: 5000 Iu, Subcutaneous. During the same period patient was treated with WARFARIN SODIUM (, Oral) (View Warfarin Sodium Review and Warfarin Sodium Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6815470-9 | Gastrointestinal Haemorrhage, Haematoma Infection, Post Procedural Haematoma, Sepsis
Patient was taking Fragmin (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, haematoma infection, post procedural haematoma, sepsis (What is sepsis?) on Jun 14, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, weighting 170.4 lb, was diagnosed with prophylaxis and. Fragmin dosage: Subcutaneous. During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), CEPHRADINE (View Cephradine Review and Cephradine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6811371-0 | Dizziness, Muscular Weakness, Vomiting
Adverse event was reported on Jun 29, 2010 by a Female patient taking Fragmin (View Usage) (Dosage: 7500 X 2 Daily Shot) was diagnosed with pulmonary thrombosis and. Location: UNITED STATES , 59 years of age, weighting 145.0 lb, After Fragmin was administered, patient had the following side effects: dizziness (What is dizziness?), muscular weakness, vomiting.

6809640-3 | Haemolysis, Liver Function Test Abnormal, Thrombocytopenia
on Jun 21, 2010 Male patient from ITALY , 98 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: haemolysis, liver function test abnormal, thrombocytopenia. Fragmin dosage: 1 Unit Daily. During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), PLACTIDIL (View Plactidil Review and Plactidil Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZOFENOPRIL (View Zofenopril Review and Zofenopril Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), NITROGLICERINA (View Nitroglicerina Review and Nitroglicerina Label ). Patient was hospitalized.

6800269-X | Diarrhoea, Paraesthesia
on Jun 02, 2010 Female patient from SWITZERLAND , 76 years of age, was treated with Fragmin (View Usage). Patient had the following side effects: diarrhoea, paraesthesia. Fragmin dosage: . During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ), TAVEGYL (CLEMASTINE) (View Tavegyl (clemastine) Review and Tavegyl (clemastine) Label ), CONDROSULF (CHONDROITIN SULFATE SODIUM) (View Condrosulf (chondroitin Sulfate Sodium) Review and Condrosulf (chondroitin Sulfate Sodium) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6786200-4 | Lung Neoplasm, Post Procedural Complication, Subcutaneous Emphysema
Patient was taking Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: lung neoplasm, post procedural complication, subcutaneous emphysema on Jun 21, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 216.1 lb, . Fragmin dosage: . During the same period patient was treated with INVANZ (View Invanz Review and Invanz Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), LORTAB (View Lortab Review and Lortab Label ), MAALOX PLUS (View Maalox Plus Review and Maalox Plus Label ), MORPHINE (View Morphine Review and Morphine Label ), TYLENOL EXTRA STR (View Tylenol Extra Str Review and Tylenol Extra Str Label ).

6781618-8 | Thrombocytopenia
Adverse event was reported on Jun 17, 2010 by a Male patient taking Fragmin (View Usage) (Dosage: ) . Location: UNITED STATES , 82 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: thrombocytopenia. During the same period patient was treated with LAMOTIL (View Lamotil Review and Lamotil Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6769605-7 | Anal Atresia, Breech Presentation, Caesarean Section, Congenital Hand Malformation, Foetal Growth Retardation, Premature Baby
on May 26, 2010 Female patient from NORWAY , weighting 4.85 lb, was diagnosed with complication of pregnancy, hypertension and was treated with Fragmin (View Usage). Patient had the following side effects: anal atresia, breech presentation, caesarean section, congenital hand malformation, foetal growth retardation, premature baby. Fragmin dosage: 5000 Iu, 1x/day, Transplacental. During the same period patient was treated with TRANDATE (100 Mg, 2x/day, Transplacental) (View Trandate Review and Trandate Label ).

6769588-X | Pancreatitis
on May 26, 2010 Male patient from GERMANY , 47 years of age, weighting 187.4 lb, was diagnosed with thrombosis prophylaxis and was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: pancreatitis. Fragmin dosage: Intramuscular.

6769565-9 | Contraindication To Medical Treatment, Haemorrhage Intracranial, Hypertension, Platelet Count Decreased, Treatment Noncompliance
Patient was taking Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: contraindication to medical treatment, haemorrhage intracranial, hypertension, platelet count decreased, treatment noncompliance on May 26, 2010 from SWEDEN Additional patient health information: Male patient , 80 years of age, . Fragmin dosage: .

6769211-4 | Amniotic Fluid Volume Decreased, Caesarean Section, Foetal Growth Retardation
Adverse event was reported on May 20, 2010 by a Female patient taking Fragmin (View Usage) (Dosage: 5000 Iu, 1xday, Transplacental) was diagnosed with assisted fertilisation and. Location: BRAZIL , weighting 5.07 lb, Patient had the following side effects: amniotic fluid volume decreased, caesarean section, foetal growth retardation.

6769186-8 | Caesarean Section, Foetal Growth Retardation, Gestational Diabetes
on May 20, 2010 Female patient from BRAZIL , 33 years of age, weighting 163.1 lb, was diagnosed with assisted fertilisation and was treated with Fragmin (View Usage). After Fragmin was administered, patient had the following side effects: caesarean section, foetal growth retardation, gestational diabetes. Fragmin dosage: 5000 Iu, 1x Day, Subcutaneous.

6754810-6 | Anal Atresia, Breech Presentation, Caesarean Section, Congenital Hand Malformation, Foetal Growth Retardation, Premature Baby
on May 14, 2010 Female patient from NORWAY , weighting 4.85 lb, was diagnosed with complication of pregnancy, hypertension and was treated with Fragmin (View Usage). Patient experienced the following unwanted or unexpected effects: anal atresia, breech presentation, caesarean section, congenital hand malformation, foetal growth retardation, premature baby. Fragmin dosage: 5000 Iu, Transplacetnal. During the same period patient was treated with VOLTAREN (50 Mg, 3x/day, Transplacental) (View Voltaren Review and Voltaren Label ), TRANDATE (100 Mg, 2x/day, Transplacental) (View Trandate Review and Trandate Label ), PARACET (PARACETAMOL) (1 G, 3x/day, Transplacetnal) (View Paracet (paracetamol) Review and Paracet (paracetamol) Label ).

6753792-0 | Platelet Count Decreased
Patient was taking Fragmin (View Usage). Patient had the following side effects: platelet count decreased on May 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 86 years of age, was diagnosed with thrombosis prophylaxis and. Fragmin dosage: Subcutaneous. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), CYCLIZINE (CYCLIZINE) (View Cyclizine (cyclizine) Review and Cyclizine (cyclizine) Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).